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Objective: Work is considered one of the main forms of social organization; however, few individuals
with schizophrenia find work opportunities. The purpose of this study was to evaluate the relationship
between schizophrenia symptoms and job acquisition.
Method: Fifty-three individuals diagnosed with schizophrenia from an outpatient treatment facility
were included in an 18-month follow-up study. After enrollment, they participated in a prevocational
training group. At the end of training (baseline) and 18 months later, sociodemographic, clinical data
and occupational history were collected. Positive and negative symptoms (Positive and Negative
Syndrome Scale – PANSS), depression (Calgary Depression Scale), disease severity (Clinical Global
Impression – CGI), functionality (Global Assessment of Functioning – GAF), personal and social
performance (Personal and Social Performance – PSP) and cognitive functions (Measurement and
Treatment Research to Improve Cognition in Schizophrenia – MATRICS battery) were applied at
baseline and at the end of the study.
Results: Those with some previous work experience (n=19) presented lower scores on the PANSS,
Calgary, GAF, CGI and PSP scales (po 0.05) than those who did not work. Among those who worked,
there was a slight worsening in positive symptoms (positive PANSS).
Conclusions: Individuals with less severe symptoms were more able to find employment. Positive
symptom changes do not seem to affect participation at work; however, this calls for discussion about
the importance of employment support.
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Introduction
An essential characteristic of schizophrenia is its impact
on psychosocial functioning, which includes impairment of
self-care, independent life skills, quality of social relations
and the capacity to work or study.1 Although multiple facets
of the disorder may contribute to functional incapacity,
cognitive functioning and the severity of negative symp-
toms have been more commonly associated with impaired
performance in activities related to social functioning, work
or study.2-4 In a systematic review, Shamsi et al.5 reviewed
predictors of functional incapacity in schizophrenia and found
that attention, processing speed, language and memory are
predictors of employability and impairments in social func-
tioning and social skills.
According to several studies, schizophrenics who are
employed report greater life satisfaction than those who
are unemployed.6-8 One of the main goals of people with
mental disorders is access to activities that are satisfying
and give meaning to life, including work. Most people with
severe mental disorders are willing and able to work9;
however, unemployment rates in this population remain
excessively high, ranging from 80 to 90%.1 These num-
bers reflect a combination of psychological and social bar-
riers, such as stigma and lack of support and professional
guidance.10-14
In a review, Bond & Drake10 highlight a schizophrenia
diagnosis and psychiatric symptoms as predictors of low
employability, while remission is a predictor of favorable
work outcomes. They emphasize that attitudes towards
individuals with schizophrenia, especially from employers,
and lack of access to support services act as barriers to
employment.
A preparatory group is a type of prevocational training
to improve work habits and personal skills. This model con-
siders that people with mental disorders need a preparation
period before seeking competitive jobs. This strategy inclu-
des participation in sheltered workshops, transition jobs,
skills training and other preparatory activities.15
It has been argued that using support strategies dur-
ing the employment process of individuals with schizo-
phrenia is important.11,14,16 However, most individuals
with serious mental disorders do not receive supported
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employment.10,16 According to Boycott et al.,17 the main
obstacles to implementing supported employment are
organizational and systemic barriers, as well as barriers
related to employment specialist competencies and atti-
tudes. Due to policy and funding restrictions within the
current Brazilian mental health care system, supported
employment for individuals with schizophrenia is still in its
incipient phase. Since supported employment programs
are generally unavailable, prevocational programs can be
a promising strategy for those who want to work.18
This study aimed to identify and analyze the relation-
ship between symptomatology and job acquisition and
retention. Individuals with schizophrenia were enrolled in
a prevocational training group and then followed up for
18 months to analyze the relationship between achieve-
ment and permanence at work and the central features
of the disorder, such as symptomatology, functionality,
social functioning and cognitive aspects. We hypothe-
sized that more favorable symptomatology profiles would
present higher rates of job acquisition and retention.
Materials and methods
Participants
All individuals undergoing treatment in the Schizophrenia
Program (Programa de Esquizofrenia – PROESQ) of
Universidade Federal de Sa˜o Paulo (UNIFESP) and the
Integrated Center for Mental Health (Centro de Atenc¸a˜o
Integrada a` Sau´de Mental – CAISM) of Santa Casa de
Sa˜o Paulo who expressed a desire for employment were
invited by their psychiatrist to participate in the study. The
psychiatrists were previously informed of the study’s
inclusion and exclusion criteria: age between 18 and
45 years (mean age: 34.2467.42), stable psychiatric symp-
toms for at least 2 months prior to enrollment, and good
treatment adherence in the psychiatrist’s opinion. The
referring psychiatrists used DSM-IV criteria for schizophre-
nia to determine the diagnosis.
All prospective participants were interviewed and allo-
cated into groups for prevocational training. Groups of
10 to 15 individuals were formed until a 1-year pre-
set deadline had expired (2012-2013). Those who had
participated in at least 6 meetings were included in the
study.
A convenience sample was formed of 53 of schizo-
phrenics desiring employment, each of whom was fol-
lowed up for 18 months. All participants were informed
that participation in this study was voluntary and would
not affect his/her treatment. All participants provided vol-
untary written informed consent, and the study was
approved by the Ethics Committee of the Universidade
Federal de Sa˜o Paulo (180.554/12).
Instruments
Clinical diagnosis data
Clinical data included onset age and duration of the dis-
order, medications, and alcohol and drug use.
Socio-occupational background
Information was obtained about the participant’s last three
periods of employment, including work hours and type of
work, social security benefits and participation in interviews.
Positive and Negative Syndrome Scale (PANSS)
This scale is used to identify and quantify positive and
negative symptoms in schizophrenia. The scale is divided
into three sections: a) positive symptoms: 7 items; b) nega-
tive symptoms: 7 items; c) general symptoms: 16 items. All
items are rated from 1 to 7 according to symptom severity
(1 = absent; 2 = minimal; 3 = mild; 4 = moderate; 5 =
moderately severe; 6 = severe; 7 = very severe). Higher
scores indicate greater severity.19
Remission criteria
Eight items on the PANSS scale are used to define remis-
sion in schizophrenia (P1 – delusions; P2 – conceptual
disorganization; P3 – hallucinatory behavior; N1 – affec-
tive blunting; N4 – social withdrawal passive/apathetic;
N6 – lack of spontaneity and fluency; G5 – mannerism/
posture; G9 – unusual thought content). Two factors are
considered necessary to fulfill remission criteria: 1)
symptomatic, all eight items must present scores p 3; 2)
temporal, remission should be sustained for 6 months.20
In the present study, both criteria were used, except that
the temporal criterion was extended to 18 months.
Calgary Depression Scale
This nine-item scale assesses depression in schizophre-
nia. For each item, the symptom is scored as absent,
mild, moderate or severe. Higher scores indicate greater
severity of depression.21
Global Assessment of Functioning (GAF)
This numeric scale (0 to 100) is used as a scoring system
for the severity of psychiatric disorders. It is a subjective
assessment of the social, occupational and psychological
functioning of patients. The scale is shown and described
in the DSM-IV-TR. The score is often given in intervals of
ten points.22
Clinical Global Impression (CGI)
This well-established rating tool is applicable to all psy-
chiatric disorders and can be easily used by practicing
clinicians.23 The CGI has two components: CGI-Severity
(CGI-S), which rates illness severity, and the CGI-
Improvement (CGI-I), which rates change from baseline.
The CGI-S rates the severity of a patient’s illness on a
7-point scale ranging from 1 (normal) to 7 (extremely ill),
according to the clinician’s experience of patients suffer-
ing from the same condition. The CGI-I assesses the
extent of a patient’s clinical change at the point of
assessment compared to baseline and also involves a
7-point range, from 1 (very much improved) to 7 (very
much worse).24
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Personal and Social Performance (PSP)
This scale measures four areas of individual functioning
and social performance (usual social activities, personal and
social relationships, self-care, aggressive and disturbed
behavior). Higher scores indicate better performance.25
The Measurement and Treatment Research to Improve
Cognition in Schizophrenia (MATRICS) cognitive battery
This recently validated instrument was an initiative to
develop a standard battery of cognitive tests for use in
clinical trials on schizophrenia.26 It consists of a set of
10 tests developed through a consensus of experts and
was designed to establish an acceptable way to evaluate
cognition-enhancing agents, thereby providing a pathway
for the approval of new medications by the U.S. Food
and Drug Administration (FDA). It was also meant to aid
standardized evaluations of other interventions to treat
the core cognitive deficits of schizophrenia. The battery
should be completed in about an hour and a half.
Grouped by cognitive domains, the battery consists of
the following tests (9 of the 10 tests were used): proces-
sing speed – Trail Making Test, Digit Symbol Coding
Subtest, and Category Fluency Test; attention/vigilance –
Continuous Performance Test (CPT); working memory –
Letters and Numbers Span Test (SPAN L N) and Spatial
Span Subtest (SPAN S); verbal learning – Hopkins Verbal
Learning Test (HVLT); visual learning – Brief Visuospatial
Memory Test (BVMT); reasoning and problem solving –
Mazes. The social cognition test was not used due to lack
of reasonable reliability in the Brazilian version.26,27
Study design
An exploratory study involving an 18-month follow-up was
conducted. The initial evaluation took place at the end of
participation in the prevocational training group (baseline),
with a subsequent evaluation 18 months later. The partici-
pants’ clinical, sociodemographic and employment history
were assessed through a socio-occupational questionnaire.
Over the 18 months, all individuals were followed
monthly through in-person meetings or telephone calls to
report their participation in job interviews, study and work.
Specific interventions to support job retention were not
performed during the study. All individuals continued
psychosocial treatment in the aforementioned services
throughout the study period. Of the 53 participants,
45 were followed up for 18 months by phone, email
or in person to report the circumstances of their job
search. All participated in initial clinical evaluations and
41 participated in a final evaluation. Among those who
did not do undergo the final clinical evaluation, three
were employed and could not miss work, and one was
incarcerated. However, there was a greater dropout rate
with the MATRICS battery, eight unexcused absences,
which left only 37 evaluations at the end of the study.
Prevocational training
The prevocational training program was carried out in
three stages: 1) weekly 1-hour meetings with those
who were as yet unsuccessful in their job search (the
main barriers identified were lack of documentation,
insecurity and fear about revealing their diagnosis); 2)
support material about the issues raised in the previous
stage was developed and shared in eight 90-minute
sessions; 3) a pilot project was carried out, followed by
support team training.
The main topics of the eight support sessions were:
1) the goals of the group; 2) how to communicate asser-
tively; 3) the importance of a good re´sume´; 4) how to write
a re´sume´; 5) how to behave in an interview; 6) stigma,
stressors and group work; 7) the importance of relation-
ships at work; 8) a farewell meeting.
All participants (n=53) completed the prevocational
training group, produced a new re´sume´ and acquired the
necessary documentation to be hired for a formal job.
It was outside the scope of the program to offer or
recommend jobs.
Data analysis
For the analysis, baseline clinical and neuropsychological
data were compared between those who worked for at
least 1 month during the 18-month follow up (employed
group [EG]) and those who did not (unemployed group
[UG]). Previous studies have considered 1 day12,14
or 1 week11 as the job acquisition criterion, although
Vauth et al.,28 used a 3-month cutoff point. In the
present study, job acquisition was defined as 1 month
of employment to enable analysis of the relation-
ship between work experience and possible changes
in symptomatology. To analyze symptom changes in
both groups during follow-up, assessments from two
different points (baseline and 18 months later) were
compared.
Statistical analysis
The sample was divided into two groups based on
job acquisition: those who obtained any kind of paid
work, either formal or informal, for at least 30 days
(EG), n=19, and those who did not (UG), n=26. Anal-
ysis included a frequency analysis and chi-square
test for categorical data, as well as the Kolmogorov-
Smirnov test to determine sample distribution. To com-
pare means, an independent t-test for parametric data and
the Mann-Whitney test for nonparametric data were used.
For repeated measures, a paired t-test was used for para-
metric data and the Wilcoxon test was used for nonpara-
metric data. Binomial logistic regression analysis was
performed to analyze job acquisition predictors.
Results
Sociodemographic data
The mean age of the original sample (n=53) was 34.23
(standard deviation [SD] = 7.42) years; the majority of
participants were men, n=38 (71.7%); 45 were single
(84.9%); the mean years of schooling were 12.51 (SD =
3.34); 37.7% had completed high school and 35.9% had
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enrolled in higher education. The mean disorder duration
was 11.92 (SD = 6.66) years. A total of 45 patients
completed the study; of those, 19 (35.8%) acquired a job,
with 10 (52.6%) earningX minimum wage. There was no
statistical difference between EG and UG regarding
gender, marital status, education, age or disorder duration
(Table 1).
Job acquisition analysis
Statistically significant differences between EG and UG
were found in most of the scales (Table 2), although there
were no significant differences in the MATRICS cognitive
battery.
At the beginning of the study, 14 (73.7%) participants
from the EG met the criteria for remission and 5 (26.3%)
did not. In the UG, 8 (30.8%) were in remission and 18
(69.2%) were not; this difference was statistically sig-
nificant (w2 = 1-8.091, p = 0.004). At the end of the study,
15 (93.7%) individuals from EG met the remission criteria
and 14 (56%) from UG were in remission, a statistically
significant difference (w2 = 1-6.716, p = 0.01).
Baseline PANSS, CGI, GAF and PSP were included in
a binomial logistic regression model. An association was
found between job acquisition and total PANSS score
(OR = 1.15, 95% confidence interval 1.06-1.25, p = 0.001).
The average length of employment in the EG was
11.55 months (SD = 6.48). Three individuals remained
employed for less than 6 months (6.8%); six (13.6%)
remained employed between 6 and 12 months and 10
(22.7%) for more than 12 months.
Symptomatic changes
The mean baseline and final evaluations were compared
to identify changes in symptoms and neuropsychology
over the follow-up period. Among the EG (n=16), the
mean PANSS positive scale was 8.31 (SD = 1.74) at
baseline and 9.69 (SD = 2.27) at the final evaluation; this
result was statistically significant (t = -2.18, degrees of
freedom = 15, p = 0.046). There were no significant
changes in PANSS negative, general psychopathology or
total score, or in Calgary, GAF, PSP or MATRICS mea-
sures. No significant results were found in the UG.
Discussion
Fifty-three individuals with schizophrenia who participa-
ted in a prevocational training program were followed for
Table 2 Comparison of baseline assessments for the employed and unemployed groups.
Employed (n=19) Unemployed (n=26) Test result*
PANSS P 8 (7/12) 12 (7/24) U = 103.5
PANSS N 14 (9/25) 21 (9/28) U = 130
PANSS Gw 23 (3.94) 29 (5.81) t = -3.979
PANSS T 44 (36/66) 61.5 (42/94) U = 74
Calgary 0 (0/2) 0.5 (0/10) U = 154
GAF 65 (55/85) 60 (20/80) U = 115.5
CGI-S 3 (2/4) 4 (2/5) U = 161
PSP 70 (50/90) 60 (40/80) U = 138
Data presented as median (minimum/maximum), unless otherwise specified.
Calgary = Calgary Depression Scale; CGI-S = Clinical Global Impression-Severity Scale; GAF = Global Assessment of Functioning; PANSS =
Positive and Negative Syndrome Scale (G = General Psychopathology Scale; N = Negative Scale; P = Positive Scale; PANSS T = Total
Score); PSP = Personal and Social Performance.
* Independent t-test or Mann-Whitney U test. All results were significant (p p 0.05).
wMean (standard deviation).
Table 1 Sociodemographic comparison of employed and unemployed schizophrenics followed up for 18 months.
Employed Unemployed p-value
Gender
Male 14 (73.7) 18 (69.2) 0.745
Female 5 (26.4) 8 (30.8)
Marital status
Single 15 (78.9) 23 (88.5) 0.665
Married 1 (5.3) 1 (3.8)
Divorced 3 (15.8) 2 (7.7)
Educational (complete or incomplete)
Elementary school 1 (5.3) 3 (11.5) 0.102
High school 11 (57.9) 15 (57.7)
Higher education 7 (36.8) 8 (30.8)
Age, mean (SD) 33.26 (7.1) 34.54 (7.6) 0.570
Disorder duration, mean (SD) 10.5 (6.6) 12.9 (6.81) 0.243
Data presented as n (%), unless otherwise specified.
The chi square test was used for comparison between groups, p p 0.05.
SD = standard deviation.
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18 months. The purpose of the study was to evaluate
factors related to finding and keeping employment and
symptom changes during the follow-up period.
We found less clinical impairment among patients in the
EG than the UG. Among those who found work (EG),
73.7% met the remission criteria at the beginning of the
study. The group also presented fewer symptoms in all
PANSS subscales, fewer depressive symptoms, better
functionality and better social performance. These results
corroborate previous studies10-14 claiming that individuals
with controlled symptoms have better performance in find-
ing work. These results point to remission as a predictor of
favorable work outcome.13,20
In the binomial regression analysis, total PANSS score
was strongly associated with employment, since less
symptomatic individuals performed better at finding work.
This corroborates the results of previous studies29-32 indi-
cating that cognitive functioning may be decisive for job
acquisition2; however, in the present study no statistically
significant results were found in the neuropsychological
evaluations. This might be explained by the relatively
small sample size.
The results suggest a worsening of positive symptoms
over time in the EG; however, this worsening – from 8.31
to 9.69 in the positive PANSS scale – is not clinically
relevant. In fact, Leddy-Stacy & Rosenheck33 suggest
that further evaluation should be performed to estimate
the minimum clinically important difference (MCID) for
these symptoms.
Considering that the employment rate for individuals
with schizophrenia ranges from 10 to 20%, our results
are encouraging, with 35.8% of all individuals gaining
some work experience during the follow-up period. These
results could be explained by the participants’ high level of
formal education,34 as well as their motivation to work35
and group support.18 However, simply obtaining a posi-
tion with satisfying work hours and wages is probably not
enough, since job retention remained problematic. At the
end of the study, only 7 EG participants (36.8%) were still
working.
Despite efforts to improve its rigor, this study has some
limitations. The sample size made it impossible to anal-
yze predictors of job retention. The sample size may have
also limited analysis of the relationship between changes
in positive symptoms and work experience, as well as
the cognitive analyses. Moreover, this is a convenience
sample of individuals with high education levels and favor-
able symptomatology who were undergoing treatment at
university outpatient clinics, which sets the analysis within
a particular context. Another limitation is related to strategy:
prevocational training is associated with lower job acquisi-
tion rates than supported employment. However, the bar-
riers to implementing supported employment in Brazil
made prevocational training more feasible.
This study’s findings are an important contribution,
especially the favorable symptomatology among patients
who found employment. Thus, it is evident that treatment
to control symptoms and increase functional capacity is
essential. Moreover, the prevocational training program
was important for overcoming initial barriers, such as lack
of official documents, fear and insecurity. The meeting
format increased motivation among members and facili-
tated an exchange of work-related experiences.35 Thus,
prevocational programs can be considered a feasible
strategy for the social insertion of similar populations.
To promote the professional inclusion of individuals
with schizophrenia, certain actions are important, such as
encouraging new ways to understand schizophrenia and
to deal with the stigma and lack of information about the
disorder.36,37 Furthermore, work engagement requires
understanding of the disorder’s impact on job acquisition
and retention, perception of how occupational stress
interferes in the disorder’s evolution, and consideration of
the specificity and combination of choices involved in the
job. Finally, job acquisition support entails avoiding occu-
pational risks and minimizing the worsening of symptoms
due to the effects of employment. In light of such condi-
tions, a case can be made for developing treatment stra-
tegies that enable social participation, normalize social
status and advocate for these individuals.38,39
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